3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasm Metastasis
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Hepatoblastoma
1
Head and Neck Neoplasms
1
HER2 Positive Advanced Gastric Cancer
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
3
Nivolumab
3
Ipilimumab
2
Interleukin-2
2
Drug Therapy
2
Biopsy
2
pertuzumab
1
osimertinib
1
montanide ISA 51
1
liposomal doxorubicin
1
cobimetinib
1
brodalumab
1
atezolizumab
1
Trastuzumab
1
Tissue Banks
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Quality of Life
1
Psychiatric Rehabilitation
1
Poly I-C
1
Photochemotherapy
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Molecular Diagnostic Techniques
1
Mass Screening
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Tissue Banks
×
Gastrointestinal
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled